94 related articles for article (PubMed ID: 33396968)
41. Injectable long-acting human immunodeficiency virus antiretroviral prodrugs with improved pharmacokinetic profiles.
Krovi SA; Gallovic MD; Keller AM; Bhat M; Tiet P; Chen N; Collier MA; Gurysh EG; Pino EN; Johnson MM; Shamim Hasan Zahid M; Cottrell ML; Pirone JR; Kashuba AD; Kwiek JJ; Bachelder EM; Ainslie KM
Int J Pharm; 2018 Dec; 552(1-2):371-377. PubMed ID: 30308272
[TBL] [Abstract][Full Text] [Related]
42. Functional biodegradable polymers via ring-opening polymerization of monomers without protective groups.
Becker G; Wurm FR
Chem Soc Rev; 2018 Oct; 47(20):7739-7782. PubMed ID: 30221267
[TBL] [Abstract][Full Text] [Related]
43. Extended-Duration MK-8591-Eluting Implant as a Candidate for HIV Treatment and Prevention.
Barrett SE; Teller RS; Forster SP; Li L; Mackey MA; Skomski D; Yang Z; Fillgrove KL; Doto GJ; Wood SL; Lebron J; Grobler JA; Sanchez RI; Liu Z; Lu B; Niu T; Sun L; Gindy ME
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012772
[TBL] [Abstract][Full Text] [Related]
44. Towards a Maraviroc long-acting injectable nanoformulation.
Tatham LM; Savage AC; Dwyer A; Siccardi M; Scott T; Vourvahis M; Clark A; Rannard SP; Owen A
Eur J Pharm Biopharm; 2019 May; 138():92-98. PubMed ID: 29684534
[TBL] [Abstract][Full Text] [Related]
45. Bone-targeting poly(ethylene sodium phosphate).
Iwasaki Y; Yokota A; Otaka A; Inoue N; Yamaguchi A; Yoshitomi T; Yoshimoto K; Neo M
Biomater Sci; 2017 Dec; 6(1):91-95. PubMed ID: 29184942
[TBL] [Abstract][Full Text] [Related]
46. Core/Shell Gene Carriers with Different Lengths of PLGA Chains to Transfect Endothelial Cells.
Duo X; Li Q; Wang J; Lv J; Hao X; Feng Y; Ren X; Shi C; Zhang W
Langmuir; 2017 Nov; 33(46):13315-13325. PubMed ID: 29100464
[TBL] [Abstract][Full Text] [Related]
47. Tenofovir disoproxil fumarate loaded PLGA nanoparticles for enhanced oral absorption: Effect of experimental variables and in vitro, ex vivo and in vivo evaluation.
Shailender J; Ravi PR; Saha P; Dalvi A; Myneni S
Colloids Surf B Biointerfaces; 2017 Oct; 158():610-619. PubMed ID: 28755558
[TBL] [Abstract][Full Text] [Related]
48. Synthesis, construction, and evaluation of self-assembled nano-bacitracin A as an efficient antibacterial agent in vitro and in vivo.
Hong W; Gao X; Qiu P; Yang J; Qiao M; Shi H; Zhang D; Tian C; Niu S; Liu M
Int J Nanomedicine; 2017; 12():4691-4708. PubMed ID: 28721045
[TBL] [Abstract][Full Text] [Related]
49. Bone-specific poly(ethylene sodium phosphate)-bearing biodegradable nanoparticles.
Hirano Y; Iwasaki Y
Colloids Surf B Biointerfaces; 2017 May; 153():104-110. PubMed ID: 28231498
[TBL] [Abstract][Full Text] [Related]
50. Joining Two Natural Motifs: Catechol-Containing Poly(phosphoester)s.
Becker G; Ackermann LM; Schechtel E; Klapper M; Tremel W; Wurm FR
Biomacromolecules; 2017 Mar; 18(3):767-777. PubMed ID: 28140560
[TBL] [Abstract][Full Text] [Related]
51. Polyphosphoesters: New Trends in Synthesis and Drug Delivery Applications.
Yilmaz ZE; Jérôme C
Macromol Biosci; 2016 Dec; 16(12):1745-1761. PubMed ID: 27654308
[TBL] [Abstract][Full Text] [Related]
52. Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy.
Owen A; Rannard S
Adv Drug Deliv Rev; 2016 Aug; 103():144-156. PubMed ID: 26916628
[TBL] [Abstract][Full Text] [Related]
53. Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers.
Schöttler S; Becker G; Winzen S; Steinbach T; Mohr K; Landfester K; Mailänder V; Wurm FR
Nat Nanotechnol; 2016 Apr; 11(4):372-7. PubMed ID: 26878141
[TBL] [Abstract][Full Text] [Related]
54. Differential Mechanisms of Tenofovir and Tenofovir Disoproxil Fumarate Cellular Transport and Implications for Topical Preexposure Prophylaxis.
Taneva E; Crooker K; Park SH; Su JT; Ott A; Cheshenko N; Szleifer I; Kiser PF; Frank B; Mesquita PM; Herold BC
Antimicrob Agents Chemother; 2015 Dec; 60(3):1667-75. PubMed ID: 26711762
[TBL] [Abstract][Full Text] [Related]
55. Enhanced transcellular penetration and drug delivery by crosslinked polymeric micelles into pancreatic multicellular tumor spheroids.
Lu H; Utama RH; Kitiyotsawat U; Babiuch K; Jiang Y; Stenzel MH
Biomater Sci; 2015 Jul; 3(7):1085-95. PubMed ID: 26221942
[TBL] [Abstract][Full Text] [Related]
56. Stabilization of DNA Structures with Poly(ethylene sodium phosphate).
Moriyama R; Iwasaki Y; Miyoshi D
J Phys Chem B; 2015 Sep; 119(36):11969-77. PubMed ID: 26173001
[TBL] [Abstract][Full Text] [Related]
57. In Vitro Virology Profile of Tenofovir Alafenamide, a Novel Oral Prodrug of Tenofovir with Improved Antiviral Activity Compared to That of Tenofovir Disoproxil Fumarate.
Callebaut C; Stepan G; Tian Y; Miller MD
Antimicrob Agents Chemother; 2015 Oct; 59(10):5909-16. PubMed ID: 26149992
[TBL] [Abstract][Full Text] [Related]
58. Hyperbranched polyphosphates: synthesis, functionalization and biomedical applications.
Liu J; Huang W; Pang Y; Yan D
Chem Soc Rev; 2015 Jun; 44(12):3942-53. PubMed ID: 26008957
[TBL] [Abstract][Full Text] [Related]
59. Poly(phosphoester)s: A New Platform for Degradable Polymers.
Steinbach T; Wurm FR
Angew Chem Int Ed Engl; 2015 May; 54(21):6098-108. PubMed ID: 25951459
[TBL] [Abstract][Full Text] [Related]
60. Patents and profits: A disparity of manufacturing margins in the tenofovir value chain.
Walwyn D
Afr J AIDS Res; 2013 Mar; 12(1):17-23. PubMed ID: 25871307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
